Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Gains from Investment Securities (2023 - 2024)

Vsee Health (VSEE) has disclosed Gains from Investment Securities for 2 consecutive years, with $43809.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Gains from Investment Securities rose 25.8% year-over-year to $43809.0, compared with a TTM value of $43809.0 through Sep 2025, down 89.01%, and an annual FY2024 reading of $407791.0, up 25117.85% over the prior year.
  • Gains from Investment Securities was $43809.0 for Q4 2024 at Vsee Health, down from $361210.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $361210.0 in Q3 2024 and bottomed at -$34758.0 in Q1 2023.